Facilitators and barriers for tuberculosis preventive treatment among patients with latent tuberculosis infection: a qualitative study

被引:6
|
作者
Manoharan, Anusha [1 ]
Farhana, H. Siti Nur [2 ]
Manimaran, K. [2 ]
Khoo, Ee Ming [3 ]
Koh, Wen Ming [4 ]
机构
[1] Bandar Bot Hlth Clin, Bandar Bot, Klang 42000, Selangor, Malaysia
[2] Minist Hlth Malaysia, Inst Hlth Behav Res, NIH, Block B3,Kompleks NIH,1,Jalan Setia Murni U13-52,S, Shah Alam 40170, Selangor, Malaysia
[3] Univ Malaya, Fac Med, Dept Primary Care Med, Kuala Lumpur 50603, Malaysia
[4] Rawang Hlth Clin, Jalan Rawang Perdana, Rawang 48000, Selangor, Malaysia
关键词
Treatment decisions; Primary care; Qualitative study; Views; Latent tuberculosis; Facilitators; Barriers; VACCINATION; FRAMEWORK; MODEL;
D O I
10.1186/s12879-023-08612-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundVarious factors influence tuberculosis preventive treatment (TPT) decisions thus it is important to understand the health beliefs and concerns of patients before starting TPT to ensure treatment compliance. This study aims to explore facilitators and barriers for TPT among patients diagnosed with Latent Tuberculosis infection (LTBI) attending six primary healthcare clinics in Selangor, Malaysia.MethodIn-depth interviews were conducted face-to-face or via telephone among patients with a clinical diagnosis of LTBI using a semi-structured topic guide developed based on the common-sense model of self-regulation and literature review. Audio recordings of interviews were transcribed verbatim and analysed thematically.ResultsWe conducted 26 In-depth interviews; Good knowledge of active tuberculosis (TB) and its associated complications, including the perceived seriousness and transmissibility of active TB, facilitates treatment. LTBI is viewed as a concern when immune status is compromised, thus fostering TPT. However, optimal health is a barrier for TPT. Owing to the lack of knowledge, patients rely on healthcare practitioners (HCPs) to determine their treatment paths. HCPs possessing comprehensive knowledge play a role in facilitating TPT whereas barriers to TPT encompass misinterpretation of tuberculin skin test (TST), inadequate explanation of TST, and apprehensions about potential medication side effects.ConclusionsKnowledge of LTBI can influence TPT uptake and patients often entrust their HCPs for treatment decisions. Improving knowledge of LTBI both among patients and HCPs can lead to more effective doctor-patient consultation and consequently boost the acceptance of TPT. Quality assurance should be enhanced to ensure the effective usage of TST as a screening tool.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study
    Xu, Weiguo
    Lu, Wei
    Zhou, Yang
    Zhu, Limei
    Shen, Hongbing
    Wang, Jianming
    BMC HEALTH SERVICES RESEARCH, 2009, 9
  • [42] Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study
    Weiguo Xu
    Wei Lu
    Yang Zhou
    Limei Zhu
    Hongbing Shen
    Jianming Wang
    BMC Health Services Research, 9
  • [43] Patients' perspectives of tuberculosis treatment challenges and barriers to treatment adherence in Ukraine: a qualitative study
    Aibana, Omowunmi
    Dauria, Emily
    Kiriazova, Tetiana
    Makarenko, Olena
    Bachmaha, Mariya
    Rybak, Natasha
    Flanigan, Timothy Palen
    Petrenko, Vasyl
    Becker, Anne E.
    Murray, Megan B.
    BMJ OPEN, 2020, 10 (01):
  • [44] Tuberculosis Infection and Latent Tuberculosis
    Lee, Seung Heon
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2016, 79 (04) : 201 - 206
  • [45] Patient Preference for Latent Tuberculosis Infection Preventive Treatment: A Discrete Choice Experiment
    Guo, Na
    Marra, Carlo A.
    FitzGerald, J. Mark
    Elwood, R. Kevin
    Anis, Aslam H.
    Marra, Fawziah
    VALUE IN HEALTH, 2011, 14 (06) : 937 - 943
  • [46] Do We Have Strategies to Improve the Preventive Treatment of Latent Tuberculosis Infection?
    Garcia, Maria J.
    Rosario Lopez, M.
    CLINICAL INFECTIOUS DISEASES, 2016, 62 (11) : 1401 - 1402
  • [47] Incidence and Risk Factors of Active Tuberculosis Among Hospitalized Patients with Latent Tuberculosis Infection in China: A Cohort Study
    Liu, Ye
    Zhang, Lifan
    Chen, Yan
    Ruan, Guiren
    Liu, Yuchen
    Chen, Shi
    Xie, Lantian
    Wu, Fengying
    Shi, Xiaochun
    Liu, Xiaoqing
    INFECTION AND DRUG RESISTANCE, 2024, 17 : 953 - 960
  • [48] Adherence to preventive treatment for latent tuberculosis infection in close contacts of pulmonary tuberculosis patients: A cluster-randomized controlled trial in China
    Chen, Hui
    Zhang, Hui
    Cheng, Jun
    Sun, Dingyong
    Wang, Qiaozhi
    Wu, Chengguo
    Liu, Yushu
    Xia, Yinyin
    Xu, Caihong
    Zhang, Canyou
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2024, 147
  • [49] PREVALENCE OF LATENT TUBERCULOSIS INFECTION AMONG PATIENTS WITH LUNG CANCER
    Kamimaki, Chisato
    Kobayashi, Nobuaki
    Hirata, Momo
    Kubo, Sousuke
    Katakura, Seigo
    Teranishi, Shuhei
    Manabe, Saki
    Yamamoto, Masaki
    Kudo, Makoto
    Kaneko, Takeshi
    RESPIROLOGY, 2019, 24 : 58 - 58
  • [50] The prevalence of latent tuberculosis infection among Iranian sarcoidosis patients
    Kiani, Arda
    Razavi, Fatemeh
    Mortaz, Esmaeil
    Emami, Habib
    Ghazali, Shima
    Anbardan, AbbasDanesh
    Mehravaran, Hossein
    Abedini, Atefeh
    BIOMEDICAL AND BIOTECHNOLOGY RESEARCH JOURNAL, 2018, 2 (04): : 247 - 253